IHS Chemical Week

Chemical Week Magazine :: Pharmaceuticals & Fine Chemicals

DSM Invests in Probiotics Startup

10:22 AM MST | November 14, 2007 | Chemical Week Editorial Staff

DSM says that its DSM Ventures subsidiary and private equity firm Capital Resource Partners (CRP; Boston) have each invested in Ganeden Biotech (Mayfield Heights, OH), a manufacturer of dietary supplements focused on digestive health. DSM and CRP have invested a combined $12 million. Further financial details were not disclosed. Ganeden’s products are based on the use of a spore-forming and lactic acid-producing bacterium, Bacillus...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week subscriber yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine a year in print or digital format
  • Real time news and analysis on chemweek.com 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now


contact us | about us | privacy policy | sitemap

ihsCopyright © IHS, Inc.All rights reserved.Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa